These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12193157)

  • 1. Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.
    Cotter MA; Jack AM; Cameron NE
    Clin Sci (Lond); 2002 Sep; 103(3):311-21. PubMed ID: 12193157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR; Gibson TM; Cotter MA; Cameron NE
    Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE; Cotter MA
    Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
    Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
    Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes.
    Cameron NE; Tuck Z; McCabe L; Cotter MA
    Diabetologia; 2001 Sep; 44(9):1161-9. PubMed ID: 11596672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice.
    Nangle MR; Cotter MA; Cameron NE
    Eur J Pharmacol; 2003 Aug; 475(1-3):99-106. PubMed ID: 12954365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory action of protein kinase Cbeta inhibitor on tetrodotoxin-resistant Na+ current in small dorsal root ganglion neurons in diabetic rats.
    Hayase F; Matsuura H; Sanada M; Kitada-Hamada K; Omatsu-Kanbe M; Maeda K; Kashiwagi A; Yasuda H
    Neurosci Lett; 2007 Apr; 417(1):90-4. PubMed ID: 17339081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models.
    Cameron N; Cotter M; Inkster M; Nangle M
    Diabetes Res Clin Pract; 2003 Jul; 61 Suppl 1():S35-9. PubMed ID: 12880693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
    Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
    Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons.
    Kim H; Sasaki T; Maeda K; Koya D; Kashiwagi A; Yasuda H
    Diabetes; 2003 Aug; 52(8):2102-9. PubMed ID: 12882929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
    Tuttle KR; Anderson PW
    Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.
    Nagareddy PR; Soliman H; Lin G; Rajput PS; Kumar U; McNeill JH; MacLeod KM
    Diabetes; 2009 Oct; 58(10):2355-64. PubMed ID: 19587355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats.
    Cotter MA; Cameron NE
    Life Sci; 2003 Aug; 73(14):1813-24. PubMed ID: 12888120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New hope for the treatment of diabetic complications.
    Corder R
    Clin Sci (Lond); 2002 Sep; 103(3):323-4. PubMed ID: 12193158
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
    Cotter MA; Ekberg K; Wahren J; Cameron NE
    Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
    Davidson EP; Coppey LJ; Holmes A; Yorek MA
    Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.